BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13

  November 5, 2024

   · 

  4 min read
• Press Releases

  Keros Therapeutics to Present at the 66th American Society of Hematology Annual Meeting and Exposition

  November 5, 2024

   · 

  4 min read
• Press Releases

  Exactech Showcases Advanced Vitamin E Polyethylene and Technologies for Knee and Hip Replacement Surgery at AAHKS 2024

  November 5, 2024

   · 

  2 min read
• Press Releases

  Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates

  November 5, 2024

   · 

  11 min read
• Press Releases

  Tessera Therapeutics to Present New Preclinical Data From In Vivo Programs for Sickle Cell Disease and T-Cell Therapies at the 66th American Society of Hematology Annual Meeting

  November 5, 2024

   · 

  2 min read
• Press Releases

  C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin’s Lymphoma at the American Society of Hematology (ASH) Annual Meeting

  November 5, 2024

   · 

  3 min read
• Press Releases

  NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024

  November 5, 2024

   · 

  3 min read
• Press Releases

  Mallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year Guidance

  November 5, 2024

   · 

  38 min read
• Press Releases

  Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates

  November 5, 2024

   · 

  6 min read
• Press Releases

  Erasca to Present at Upcoming Investor Conferences

  November 5, 2024

   · 

  1 min read